AstraZeneca said its late-stage trial that showed the drug reduced the risk of people developing any COVID-19 symptoms by 77 per cent.
AstraZeneca seeks U.S. emergency approval for COVID-19 prevention drug
AstraZeneca said its late-stage trial that showed the drug reduced the risk of people developing any COVID-19 symptoms by 77 per cent.